Botanical species · safety record

Origanum majorana

The EFSA Compendium of Botanicals holds 5 constituent measurements for Origanum majorana. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Origanum majorana L.

5Constituent measurements

0Safety records

5Cited sources

142Licensed products (Canada)

Also recorded as

Majorana hortensis Moench
Origanum dubium Boiss.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 142 licensed products naming Origanum majorana as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Fresh

Source material stated

Flowering grass
Flowering herb
Herb flowering
Herb top
Herb top flowering
Herb top flowering or leaf
Herb when in flower
Leaf

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	—	Essential oil	41.5 Percent	GC-MS	Resolve DOI
Myrcene	Leaves	Essential oil	1.3 Percent	Gaschromatography (GC)	Resolve DOI
(-)-camphor	Leaves	Essential oil	5.61 Percent	GC-MS	No resolvable identifier
Myrcene	Leaves	Essential oil	2.08 Percent	GC-MS	No resolvable identifier
Piperidine	Live plants	Solvent extraction	—	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Nardin, Tiziana., Piasentier, Edi., Barnaba, Chiara., Larcher, Roberto. Alkaloid profiling of herbal drugs using high resolution mass spectrometry. Drug testing and analysis, 2017, p. Ahead of Print.
Daferera, DJ., Ziogas, BN., Polissiou, MG. The effectiveness of plant essential oils on the growth of Botrytis cinerea, Fusarium sp and Clavibacter michiganensis subsp michiganensis . Crop protection, 2003, vol. 22, no. 1, p. 39-44. DOI
Dantas, Andrea Dos Santos., Klein-Junior, Luiz Carlos., Machado, Miriana S., Guecheva, Temenouga N., Dos Santos, Luciana D., Zanette, Regis A., de Mello, Fernanda B., Pegas Henriques, Joao Antonio., de Mello, Joao Roberto Braga. Origanum majorana Essential Oil Lacks Mutagenic Activity in the Salmonella/Microsome and Micronucleus Assays. . Thescientificworldjournal, 2016, vol. 2016, p. 3694901-3694901.
Jang, YS., Yang, YC., Choi, DS., Ahn, YJ. Vapor phase toxicity of marjoram oil compounds and their related monoterpenoids to Blattella germanica (Orthoptera : Blattellidae) . Journal of agricultural and food chemistry, 2005, vol. 53, no. 20, p. 7892-7898. DOI
Karawya, M. S., Balbaa, S. I., Hifnawy, M. S. M. Essential oils of certain labiaceous plants of Egypt. American perfumer and cosmetics, 1970, vol. 85, no. 8, p. 23-8.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature